CytomX Therapeutics, Inc.

DB:6C1 Stock Report

Market Cap: €323.9m

CytomX Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:6C1 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Mar 24Sell€12,601Jeffrey LandauIndividual6,562€1.92
19 Mar 24Sell€24,571Marcia BelvinIndividual12,795€1.92
19 Mar 24Sell€5,705Christopher OgdenIndividual2,971€1.92
19 Mar 24Sell€38,835Sean McCarthyIndividual20,223€1.92
19 Mar 24Sell€10,116Lloyd RowlandIndividual5,268€1.92
20 Dec 23Sell€2,504Christopher OgdenIndividual1,990€1.26
20 Dec 23Sell€5,131Lloyd RowlandIndividual4,077€1.26
20 Dec 23Sell€5,130Marcia BelvinIndividual4,077€1.26
20 Dec 23Sell€5,130Jeffrey LandauIndividual4,077€1.26
20 Dec 23Sell€17,054Sean McCarthyIndividual13,551€1.26
22 Sep 23Sell€6,696Lloyd RowlandIndividual5,486€1.22
22 Sep 23Sell€17,818Sean McCarthyIndividual14,601€1.22
22 Sep 23Sell€5,026Jeffrey LandauIndividual4,119€1.22
22 Sep 23Sell€5,026Marcia BelvinIndividual4,119€1.22

Insider Trading Volume

Insider Buying: 6C1 insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of 6C1?
Owner TypeNumber of SharesOwnership Percentage
Private Companies7,1840.0106%
Individual Insiders737,5881.09%
Hedge Funds13,145,80119.4%
Institutions19,477,38628.8%
General Public34,363,80550.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.1%.


Top Shareholders

Top 25 shareholders own 47.11% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.74%
BVF Partners L.P.
6,595,801€31.5m0%0.26%
9.67%
Tang Capital Management, LLC
6,550,000€31.3m1.55%1.18%
7.24%
The Vanguard Group, Inc.
4,902,943€23.4m0%no data
3.91%
Acadian Asset Management LLC
2,646,190€12.7m0%0.01%
1.96%
Renaissance Technologies LLC
1,325,700€6.3m42.5%no data
1.68%
BlackRock, Inc.
1,136,135€5.4m-0.31%no data
1.62%
Laurion Capital Management LP
1,093,921€5.2m-7.94%0.06%
1.36%
Bronte Capital Management Pty Ltd
919,911€4.4m-0.58%0.09%
1.17%
Millennium Management LLC
794,047€3.8m13.6%no data
1.17%
Jacobs Levy Equity Management Inc
791,421€3.8m-24.8%0.01%
1.04%
Geode Capital Management, LLC
702,654€3.4m3.89%no data
0.83%
FMR LLC
565,311€2.7m-20.1%no data
0.78%
Sean McCarthy
529,907€2.5m37.1%no data
0.64%
Bridgeway Capital Management, LLC
434,524€2.1m16.8%0.01%
0.6%
Assenagon Asset Management S.A.
404,674€1.9m0%no data
0.54%
Marshall Wace LLP
363,276€1.7m-3.79%no data
0.45%
Formidable Asset Management, LLC
306,107€1.5m-3.77%0.11%
0.45%
Tidal Investments LLC
306,107€1.5m-3.77%0.01%
0.39%
State Street Global Advisors, Inc.
267,476€1.3m0%no data
0.37%
Citadel Advisors LLC
253,283€1.2m321%no data
0.36%
BNY Mellon Asset Management
241,981€1.2m-9.31%no data
0.35%
Congress Park Capital LLC
233,800€1.1m-2.3%0.17%
0.29%
Clearline Capital LP
196,583€940.1k0%0.03%
0.29%
Connor, Clark & Lunn Investment Management Ltd.
196,520€939.8k34.7%no data
0.22%
Squarepoint OPS LLC
150,533€719.9k-13.3%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.